Literature DB >> 31227334

Pathogenic Autoreactive T and B Cells Cross-React with Mimotopes Expressed by a Common Human Gut Commensal to Trigger Autoimmunity.

William E Ruff1, Carina Dehner1, Woo J Kim1, Odelya Pagovich1, Cassyanne L Aguiar2, Andrew T Yu1, Alexander S Roth1, Silvio Manfredo Vieira1, Christina Kriegel1, Olamide Adeniyi1, Melissa J Mulla3, Vikki M Abrahams3, William W Kwok4, Ruth Nussinov5, Doruk Erkan2, Andrew L Goodman6, Martin A Kriegel7.   

Abstract

Given the immense antigenic load present in the microbiome, we hypothesized that microbiota mimotopes can be a persistent trigger in human autoimmunity via cross-reactivity. Using antiphospholipid syndrome (APS) as a model, we demonstrate cross-reactivity between non-orthologous mimotopes expressed by a common human gut commensal, Roseburia intestinalis (R. int), and T and B cell autoepitopes in the APS autoantigen β2-glycoprotein I (β2GPI). Autoantigen-reactive CD4+ memory T cell clones and an APS-derived, pathogenic monoclonal antibody cross-reacted with R. int mimotopes. Core-sequence-dependent anti-R. int mimotope IgG titers were significantly elevated in APS patients and correlated with anti-β2GPI IgG autoantibodies. R. int immunization of mice induced β2GPI-specific lymphocytes and autoantibodies. Oral gavage of susceptible mice with R. int induced anti-human β2GPI autoantibodies and autoimmune pathologies. Together, these data support a role for non-orthologous commensal-host cross-reactivity in the development and persistence of autoimmunity in APS, which may apply more broadly to human autoimmune disease.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bacteroides thetaiotaomicron; DNA methyltransferase; IgA-coated bacteria; Th1 cell clones; apolipoprotein H; calprotectin; microbiotme; molecular mimicry; systemic autoimmunity; thrombosis

Mesh:

Substances:

Year:  2019        PMID: 31227334      PMCID: PMC8194364          DOI: 10.1016/j.chom.2019.05.003

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  93 in total

1.  Investigating deep phylogenetic relationships among cyanobacteria and plastids by small subunit rRNA sequence analysis.

Authors:  S Turner; K M Pryer; V P Miao; J D Palmer
Journal:  J Eukaryot Microbiol       Date:  1999 Jul-Aug       Impact factor: 3.346

2.  Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform.

Authors:  James J Kozich; Sarah L Westcott; Nielson T Baxter; Sarah K Highlander; Patrick D Schloss
Journal:  Appl Environ Microbiol       Date:  2013-06-21       Impact factor: 4.792

3.  Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI.

Authors:  G M Iverson; E J Victoria; D M Marquis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

4.  Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5.

Authors:  Matam Vijay-Kumar; Jesse D Aitken; Frederic A Carvalho; Tyler C Cullender; Simon Mwangi; Shanthi Srinivasan; Shanthi V Sitaraman; Rob Knight; Ruth E Ley; Andrew T Gewirtz
Journal:  Science       Date:  2010-03-04       Impact factor: 47.728

5.  Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients.

Authors:  R Cervera; R Serrano; G J Pons-Estel; L Ceberio-Hualde; Y Shoenfeld; E de Ramón; V Buonaiuto; S Jacobsen; M M Zeher; T Tarr; A Tincani; M Taglietti; G Theodossiades; E Nomikou; M Galeazzi; F Bellisai; P L Meroni; R H W M Derksen; P G D de Groot; M Baleva; M Mosca; S Bombardieri; F Houssiau; J-C Gris; I Quéré; E Hachulla; C Vasconcelos; A Fernández-Nebro; M Haro; Z Amoura; M Miyara; M Tektonidou; G Espinosa; M L Bertolaccini; M A Khamashta
Journal:  Ann Rheum Dis       Date:  2014-01-24       Impact factor: 19.103

6.  Antiphospholipid antibody-induced miR-146a-3p drives trophoblast interleukin-8 secretion through activation of Toll-like receptor 8.

Authors:  Stefan M Gysler; Melissa J Mulla; Marta Guerra; Jan J Brosens; Jane E Salmon; Lawrence W Chamley; Vikki M Abrahams
Journal:  Mol Hum Reprod       Date:  2016-03-29       Impact factor: 4.025

Review 7.  The gut microbiota influences anticancer immunosurveillance and general health.

Authors:  Bertrand Routy; Vancheswaran Gopalakrishnan; Romain Daillère; Laurence Zitvogel; Jennifer A Wargo; Guido Kroemer
Journal:  Nat Rev Clin Oncol       Date:  2018-06       Impact factor: 66.675

8.  Variability in exposure of epitope G40-R43 of domain i in commercial anti-beta2-glycoprotein I IgG ELISAs.

Authors:  Leonie Pelkmans; Hilde Kelchtermans; Philip G de Groot; Stephane Zuily; Veronique Regnault; Denis Wahl; Vittorio Pengo; Bas de Laat
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

9.  Improvements to PATRIC, the all-bacterial Bioinformatics Database and Analysis Resource Center.

Authors:  Alice R Wattam; James J Davis; Rida Assaf; Sébastien Boisvert; Thomas Brettin; Christopher Bun; Neal Conrad; Emily M Dietrich; Terry Disz; Joseph L Gabbard; Svetlana Gerdes; Christopher S Henry; Ronald W Kenyon; Dustin Machi; Chunhong Mao; Eric K Nordberg; Gary J Olsen; Daniel E Murphy-Olson; Robert Olson; Ross Overbeek; Bruce Parrello; Gordon D Pusch; Maulik Shukla; Veronika Vonstein; Andrew Warren; Fangfang Xia; Hyunseung Yoo; Rick L Stevens
Journal:  Nucleic Acids Res       Date:  2016-11-29       Impact factor: 16.971

10.  Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation.

Authors:  Benoit Chassaing; Gayathri Srinivasan; Maria A Delgado; Andrew N Young; Andrew T Gewirtz; Matam Vijay-Kumar
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

View more
  34 in total

1.  Gut dysbiosis modulates the immune response to factor VIII in murine hemophilia A.

Authors:  Julie Tarrant; Matthew Cormier; Kate Nesbitt; Courtney Dwyer; Christine Hough; David Lillicrap
Journal:  Blood Adv       Date:  2020-06-23

Review 2.  Host-microbiota interactions in immune-mediated diseases.

Authors:  William E Ruff; Teri M Greiling; Martin A Kriegel
Journal:  Nat Rev Microbiol       Date:  2020-05-26       Impact factor: 60.633

Review 3.  Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome.

Authors:  Ziying Zhang; Haosheng Tang; Peng Chen; Hui Xie; Yongguang Tao
Journal:  Signal Transduct Target Ther       Date:  2019-10-12

Review 4.  Systemic Lupus Erythematosus and dysbiosis in the microbiome: cause or effect or both?

Authors:  Gregg J Silverman; Doua F Azzouz; Alexander V Alekseyenko
Journal:  Curr Opin Immunol       Date:  2019-10-04       Impact factor: 7.486

Review 5.  Gut Microbiota in Lupus: a Butterfly Effect?

Authors:  Rongli Li; Xia Meng; Beidi Chen; Lidan Zhao; Xuan Zhang
Journal:  Curr Rheumatol Rep       Date:  2021-04-16       Impact factor: 4.592

6.  Altered Systemic and Intestinal IgA Immune Responses in Individuals With Type 1 Diabetes.

Authors:  Juan Huang; Gan Huang; Xia Li; Fang Hu; Zhiguo Xie; Yang Xiao; Shuoming Luo; Chen Chao; Keyu Guo; F Susan Wong; Zhiguang Zhou; Li Wen
Journal:  J Clin Endocrinol Metab       Date:  2020-12-01       Impact factor: 5.958

Review 7.  Partners in Leaky Gut Syndrome: Intestinal Dysbiosis and Autoimmunity.

Authors:  Yusuke Kinashi; Koji Hase
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

Review 8.  The Autoantigen Repertoire and the Microbial RNP World.

Authors:  Sandra G Williams; Sandra L Wolin
Journal:  Trends Mol Med       Date:  2021-03-12       Impact factor: 11.951

Review 9.  B Cells and Microbiota in Autoimmunity.

Authors:  María Botía-Sánchez; Marta E Alarcón-Riquelme; Georgina Galicia
Journal:  Int J Mol Sci       Date:  2021-05-03       Impact factor: 5.923

10.  Effects of sepsis and its treatment measures on intestinal flora structure in critical care patients.

Authors:  Xiao-Juan Yang; Dan Liu; Hong-Yan Ren; Xiao-Ya Zhang; Jun Zhang; Xiao-Jun Yang
Journal:  World J Gastroenterol       Date:  2021-05-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.